上海毕得医药科技股份有限公司

Core Viewpoint - The company held its 21st meeting of the second board of directors on April 23, 2025, where several key resolutions were passed regarding the 2024 annual reports and future plans [5][4]. Group 1: Board Meeting Resolutions - The board approved the 2024 annual work report, confirming compliance with legal and regulatory requirements [6][7]. - The 2024 annual general manager's work report was also approved, reflecting the company's operational activities accurately [9][10]. - The financial settlement report for 2024 was approved, showing a revenue of CNY 1,102,010,333.61 and a net profit of CNY 117,426,163.51 [11][13]. - The profit distribution plan for 2024 was approved, proposing a cash dividend of CNY 9 per 10 shares, totaling CNY 78,179,748.30 [15][16]. - The remuneration plan for directors and senior management for 2025 was approved, pending further shareholder approval [18][19]. Group 2: Financial Reports and Audits - The board approved the 2024 internal control evaluation report, indicating effective governance and compliance [23][24]. - The 2024 annual report and summary were approved, confirming that the information presented is accurate and complete [27][30]. - The first quarter report for 2025 was also approved, reflecting the company's financial status accurately [31][70]. Group 3: Fund Management and Usage - The company plans to use idle funds for cash management, with a maximum of CNY 10 billion for a period not exceeding 12 months [94]. - The company reported a balance of CNY 38,899.15 million in unused funds as of December 31, 2024 [76]. - The company has established a management system for the use of raised funds, ensuring compliance with relevant regulations [77][78]. Group 4: Asset Impairment and Financial Health - The company reported an asset impairment provision of CNY 37.75 million for the year ending December 31, 2024, primarily due to inventory and credit losses [90][92]. - The company confirmed that the impairment provisions align with accounting standards and reflect its financial health accurately [93].